A comprehensive review of drug-resistant epilepsy and animal models: Existing and emerging therapies and future research directions

Epilepsy is a long-term neurological disorder that results in recurring, uncontrolled seizures. These kinds of seizures are caused by excessively high and irregular electrical discharge in the central nervous system. Epilepsy is among the most common neurological disorders, with approximately 50–70 new cases/100,000 people every year. This review critically examines the current landscape of pharmacological experimental animal models employed in the study of drug-resistant and refractory epilepsy, shedding light on the complexities of this multifaceted disorder. Through an extensive analysis of preclinical models, the review explores the diverse mechanisms underlying resistance to antiepileptic drugs, emphasizing the need for innovative therapeutic strategies. This review was conducted using a comprehensive search of databases, including PubMed, Scopus, and Web of Science, focusing on studies published from 2000 to 2024. Articles were selected based on relevance to drug-resistant epilepsy (DRE) models, emerging technologies, and translational potential, using keywords such as DRE, animal models, and epileptogenesis. In addition, emerging experimental approaches, such as optogenetics, chemogenetics, and advanced imaging techniques, were scrutinized. Furthermore, this review outlines innovative approaches, including novel pharmacotherapies, gene therapies, and precision medicine interventions, that hold promise for overcoming drug resistance. By synthesizing current knowledge and identifying gaps, this article aims to guide future research directions and stimulate innovative strategies for developing effective interventions for drug-resistant and refractory epilepsy. Ultimately, a comprehensive grasp of experimental models and innovative approaches is crucial for advancing our understanding of epilepsy pathophysiology and paving the way for more efficacious and personalized therapeutic interventions.

Authors

Publication Details

Journal
Advanced Neurology
Published
2025-08-14
DOI
https://doi.org/10.36922/an025210062
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A comprehensive review of drug-resistant epilepsy and animal models: Existing and emerging therapies and future research directions

Aman Shrivastava, Prerna Chaturvedi, Amit Ȧnand, Sumeet Dwivedi et al.
Advanced Neurology
Neuroscience and Neuropharmacology Research
article

A comprehensive review of drug-resistant epilepsy and animal models: Existing and emerging therapies and future research directions

Aman Shrivastava, Prerna Chaturvedi, Amit Ȧnand, Sumeet Dwivedi, Sonam Upadhyay, Diksha Sharma
article en

Abstract

Epilepsy is a long-term neurological disorder that results in recurring, uncontrolled seizures. These kinds of seizures are caused by excessively high and irregular electrical discharge in the central nervous system. Epilepsy is among the most common neurological disorders, with approximately 50–70 new cases/100,000 people every year. This review critically examines the current landscape of pharmacological experimental animal models employed in the study of drug-resistant and refractory epilepsy, shedding light on the complexities of this multifaceted disorder. Through an extensive analysis of preclinical models, the review explores the diverse mechanisms underlying resistance to antiepileptic drugs, emphasizing the need for innovative therapeutic strategies. This review was conducted using a comprehensive search of databases, including PubMed, Scopus, and Web of Science, focusing on studies published from 2000 to 2024. Articles were selected based on relevance to drug-resistant epilepsy (DRE) models, emerging technologies, and translational potential, using keywords such as DRE, animal models, and epileptogenesis. In addition, emerging experimental approaches, such as optogenetics, chemogenetics, and advanced imaging techniques, were scrutinized. Furthermore, this review outlines innovative approaches, including novel pharmacotherapies, gene therapies, and precision medicine interventions, that hold promise for overcoming drug resistance. By synthesizing current knowledge and identifying gaps, this article aims to guide future research directions and stimulate innovative strategies for developing effective interventions for drug-resistant and refractory epilepsy. Ultimately, a comprehensive grasp of experimental models and innovative approaches is crucial for advancing our understanding of epilepsy pathophysiology and paving the way for more efficacious and personalized therapeutic interventions.

Advanced NeurologyVol. 0(0)
Openalex Percentile: Top 77%
Neuroscience and Neuropharmacology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A comprehensive review of drug-resistant epilepsy and animal models: Existing and emerging therapies and future research directions — Aman Shrivastava, Prerna Chaturvedi, et al. · Advanced Neurology (2025) | TGRS Research Map | TGRS